2m 2m 2m 2m 2m 2m 2m
PAVMED (PAVM)
NASDAQ
$5.86-$0.14 (-2.42%)
Price as of Jun 03, 2026 6:41 PM EDT- $44.4MMarket Cap
- -66.64%1-Year Change
- Medical DevicesIndustry
PAVMED (PAVM)
$5.86-$0.14 (-2.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 71,000 -97.63% | 3.0M +22.15% | 2.5M +550.40% | 377,000 -24.60% | |
Cost of Revenue | 218,000 -95.50% | 4.8M -24.61% | 6.4M +77.64% | 3.6M +517.78% | |
Gross Profit | -147,000 -92.03% | -1.8M -53.50% | -4.0M +22.58% | -3.2M +3,708.24% | |
Sales and Marketing Expense | 917,000 -92.11% | 11.6M -33.87% | 17.6M -8.98% | 19.3M +117.18% | |
Research and Development Expense | -4.5M -24.28% | -5.9M -58.45% | -14.3M -44.12% | -25.5M +28.72% | |
Depreciation and Amortization Expense | 105,000 -91.24% | 1.2M -59.14% | 2.9M +19.33% | 2.5M +2,971.25% | |
Total Operating Expenses | 21.9M -53.93% | 47.5M -33.36% | 71.2M -21.97% | 91.3M +68.12% | |
Operating Profit | -21.8M -50.98% | -44.5M -35.33% | -68.8M -24.34% | -90.9M +67.17% | |
Interest Income | 29,000 -88.58% | 254,000 -49.70% | 505,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | -45,000 -92.36% | -589,000 -53.69% | -1.3M N/A | |
Interest Income and Expense and Net | 29,000 -86.12% | 209,000 +348.81% | -84,000 -93.40% | -1.3M N/A | |
Total Nonoperating Income and Expense | 19.3M -73.48% | 72.9M +796.54% | -10.5M -14.97% | -12.3M +610.39% | |
Income before Taxes | -2.5M -108.69% | 28.4M +135.86% | -79.3M -23.22% | -103.2M +83.94% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 401,000 -98.99% | 39.8M +162.00% | -64.2M -27.88% | -89.0M +76.74% | |
Net Income from Continuing Operations Applicable to Common | -3.8M -111.81% | 32.0M +148.24% | -66.3M -25.76% | -89.3M +76.31% | |
Basic EPS and Net Income | -5.63 -270.61% | 3.30 +136.03% | -9.16 +816.00% | -1.00 +53.85% | |
Diluted EPS and Net Income | -5.63 -1,226.00% | 0.50 +105.46% | -9.16 +816.00% | -1.00 +53.85% | |
Basic Weighted Average Shares | 670,466 -93.07% | 9.7M +33.75% | 7.2M -91.88% | 89.1M +14.91% | |
Diluted Weighted Average Shares | 670,466 -98.97% | 65.3M +802.87% | 7.2M -91.88% | 89.1M +14.91% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.5M +29.79% | 1.2M -93.97% | 19.6M -50.59% | 39.7M -48.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.5M +29.79% | 1.2M -93.97% | 19.6M -50.59% | 39.7M -48.56% | |
Total Current Assets | 2.6M +18.16% | 2.2M -91.17% | 24.5M -44.23% | 43.9M -46.84% | |
Accumulated Depreciation | 1.4M +8.38% | 1.3M -27.11% | 1.7M +112.75% | 808,000 +485.51% | |
Property and Plant and Equipment and Net | 77,000 -49.01% | 151,000 -91.53% | 1.8M -27.25% | 2.5M +54.64% | |
Total Long-Term Assets | 56,000 -73.08% | 208,000 -81.87% | 1.1M +2.32% | 1.1M +54.62% | |
Total Assets | 38.8M +26.59% | 30.7M -7.42% | 33.1M -38.65% | 54.0M -37.94% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 11.1M -61.86% | 29.1M -34.16% | 44.2M +31.35% | 33.6M N/A | |
Total Current Liabilities | 14.8M -58.14% | 35.4M -34.57% | 54.2M +31.50% | 41.2M +445.12% | |
Total Long-Term Debt | 32.4M +1,520.75% | 2.0M -99.90% | 2.0B N/A | N/A N/A | |
Total Long-Term Liabilities | 1.7M -25.46% | 2.2M -24.09% | 3.0M +60.35% | 1.8M N/A | |
Total Liabilities | 16.5M -56.19% | 37.7M -34.03% | 57.1M +32.73% | 43.0M +469.54% | |
Retained Earnings | -258.7M +1.48% | -255.0M -13.40% | -294.4M +29.04% | -228.2M +64.26% | |
Total Stockholders Equity | 34.0M +1,461.40% | -2.5M -95.37% | -53.8M +456.05% | -9.7M -115.70% | |
Total Shares Outstanding | 927,934 -91.71% | 11.2M +30.55% | 8.6M -90.92% | 94.5M +9.43% | |
Cash Flow | |||||
Cash from Operating Activities | -5.2M -84.48% | -33.6M -35.52% | -52.0M -26.69% | -71.0M +74.88% | |
Capital Expenditures | 31,000 -43.64% | 55,000 -77.27% | 242,000 -84.29% | 1.5M +4.83% | |
Cash from Investing Activities | -31,000 -99.81% | -16.2M -2,235.09% | 758,000 +115.99% | -4.7M +27.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.6M -82.13% | 31.3M +0.36% | 31.2M -18.42% | 38.2M -63.37% | |
Financials Ratio | |||||
Gross Margin | -207.04% +236.09% | -61.60% -61.93% | -161.83% -81.15% | -858.62% +4,950.71% | |
Operating Margin | -30,712.68% +1,967.67% | -1,485.38% -47.06% | -2,805.67% -88.37% | -24,118.57% +121.71% | |
Return on Assets | 1.15% -99.07% | 124.78% +184.67% | -147.36% +16.72% | -126.26% +33.85% | |
Return on Equity | 2.55% +101.80% | -141.29% -169.91% | 202.09% +159.03% | -342.34% +116.10% | |
Revenue Growth | -97.63% -540.86% | 22.15% -95.98% | 550.40% +2,337.39% | -24.60% N/A | |
Current Ratio | 0.17 +182.00% | 0.06 -86.49% | 0.45 -57.59% | 1.07 -90.25% | |
Cash Ratio | 0.10 +210.48% | 0.03 -90.79% | 0.36 -62.42% | 0.96 -90.56% | |
Debt-to-Equity Ratio | 1.28 +110.28% | -12.46 -67.18% | -37.97 N/A | N/A N/A | |
Debt-to-Assets Ratio | 1.12 +10.53% | 1.01 -98.36% | 61.72 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow